We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+2.82%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$231B
AUM Growth
-$701M
Cap. Flow
-$4.96B
Cap. Flow %
-2.15%
Top 10 Hldgs %
13.13%
Holding
8,738
New
866
Increased
3,703
Reduced
3,052
Closed
702

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$514M
2
MDLZ icon
Mondelez International
MDLZ
+$421M
3
COR icon
Cencora
COR
+$225M
4
IVZ icon
Invesco
IVZ
+$212M
5
MON
Monsanto Co
MON
+$205M

Sector Composition

Rank Sector Weight
1 Technology 8.74%
2 Financials 7.28%
3 Healthcare 6.05%
4 Consumer Discretionary 5.36%
5 Energy 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDR
5226
DELISTED
Cedar Realty Trust, Inc
CDR
$133K ﹤0.01%
4,247
+1,287
+43% +$35.5K
BRSS
5227
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
$133K ﹤0.01%
4,254
+3,468
+441% +$111K
FTRPR
5228
DELISTED
Frontier Communications Corporation 11.125% Series A Mandatory Convertible Preferred Stock
FTRPR
$133K ﹤0.01%
13,494
-22,485
-62% -$297K
BHVN
5229
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$133K ﹤0.01%
3,360
+1,046
+45% +$33.2K
IHG icon
5230
InterContinental Hotels
IHG
$23.2B
$132K ﹤0.01%
2,003
-63
-3% -$4.23K
ULVM icon
5231
VictoryShares US Value Momentum ETF
ULVM
$269M
$132K ﹤0.01%
2,557
+1,757
+220% +$91.3K
WSO.B
5232
Watsco Inc Class B
WSO.B
$132K ﹤0.01%
742
LAUR icon
5233
Laureate Education
LAUR
$5.28B
$131K ﹤0.01%
9,152
-78,541
-90% -$1.16M
EGIO
5234
DELISTED
Edgio, Inc. Common Stock
EGIO
$131K ﹤0.01%
733
+404
+123% +$78.3K
GCP
5235
DELISTED
GCP Applied Technologies Inc.
GCP
$131K ﹤0.01%
4,531
-251
-5% -$7.6K
VSLR
5236
DELISTED
VIVINT SOLAR, INC.
VSLR
$131K ﹤0.01%
26,368
+25,668
+3,667% +$108K
BRSL
5237
CALL
Brightstar Lottery PLC
BRSL
$2.03B
$130K ﹤0.01%
5,600
-18,300
-77% -$487K
MCRI icon
5238
Monarch Casino & Resort
MCRI
$2.23B
$130K ﹤0.01%
2,946
+1,436
+95% +$63.2K
NSLR
5239
Neostellar Capital Corp
NSLR
$254M
$130K ﹤0.01%
22,487
+2,216
+11% +$13K
NUM
5240
DELISTED
Nuveen Michigan Quality Municipal Income Fund
NUM
$130K ﹤0.01%
10,260
-2,359
-19% -$29.8K
CEW
5241
WisdomTree Emerging Currency Strategy Fund
CEW
$17.9M
$129K ﹤0.01%
6,951
-541
-7% -$10.4K
EML icon
5242
Eastern Company
EML
$150M
$129K ﹤0.01%
4,590
-605
-12% -$17.8K
GSEW icon
5243
Goldman Sachs Equal Weight US Large Cap Equity ETF
GSEW
$1.97B
$129K ﹤0.01%
2,934
-750
-20% -$32.8K
HURN icon
5244
Huron Consulting
HURN
$2.42B
$129K ﹤0.01%
3,156
+2,425
+332% +$94.4K
OSBC icon
5245
Old Second Bancorp
OSBC
$1.29B
$129K ﹤0.01%
8,991
+3,711
+70% +$54.2K
EGF
5246
DELISTED
Blackrock Enhanced Government Fund, Inc.
EGF
$129K ﹤0.01%
9,990
-16,144
-62% -$209K
AVEO
5247
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$129K ﹤0.01%
5,734
+5,724
+57,240% +$136K
NXN
5248
DELISTED
Nuveen New York Tax-Free Income Portfolio
NXN
$128K ﹤0.01%
9,790
-239
-2% -$3.06K
PNI
5249
PIMCO New York Municipal Income Fund II
PNI
$77.7M
$128K ﹤0.01%
12,059
-5,686
-32% -$60.2K
NTUS
5250
DELISTED
Natus Medical Inc
NTUS
$128K ﹤0.01%
3,710
-2,108
-36% -$73.9K

Similar funds

UBS Group's Q2 2018 Portfolio in Review

As of Q2 2018, UBS Group held 8,738 positions worth $231B, down 0.3% from $232B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q2 2018 filing shows 866 new, 3,703 increased, 3,052 reduced and 702 closed positions. Its largest new stake was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M. The largest sale was NXP Semiconductors, an estimated $514M.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 8.1% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2018 buy was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $1.01B increase.
  • UBS Group's biggest Q2 2018 reduction was NXP Semiconductors, cutting an estimated $514M.
  • UBS Group fully exited Monsanto Co in Q2 2018, selling an estimated $205M.
  • UBS Group's ten largest holdings make up 13% of its $231B portfolio in Q2 2018.
  • UBS Group opened 866 new positions and closed 702 in Q2 2018.
  • UBS Group's portfolio value fell 0.3% quarter-over-quarter to $231B.

Based on UBS Group's 13F filing for Q2 2018, filed 14 Aug 2018.